» Articles » PMID: 21035952

Real-time Study of Prostate Intrafraction Motion During External Beam Radiotherapy with Daily Endorectal Balloon

Overview
Specialties Oncology
Radiology
Date 2010 Nov 2
PMID 21035952
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To prospectively investigate intrafraction prostate motion during radiofrequency-guided prostate radiotherapy with implanted electromagnetic transponders when daily endorectal balloon (ERB) is used.

Methods And Materials: Intrafraction prostate motion from 24 patients in 787 treatment sessions was evaluated based on three-dimensional (3D), lateral, cranial-caudal (CC), and anterior-posterior (AP) displacements. The mean percentage of time with 3D, lateral, CC, and AP prostate displacements>2, 3, 4, 5, 6, 7, 8, 9, and 10 mm in 1 minute intervals was calculated for up to 6 minutes of treatment time. Correlation between the mean percentage time with 3D prostate displacement>3 mm vs. treatment week was investigated.

Results: The percentage of time with 3D prostate movement>2, 3, and 4 mm increased with elapsed treatment time (p<0.05). Prostate movement>5 mm was independent of elapsed treatment time (p=0.11). The overall mean time with prostate excursions>3 mm was 5%. Directional analysis showed negligible lateral prostate motion; AP and CC motion were comparable. The fraction of time with 3D prostate movement>3 mm did not depend on treatment week of (p>0.05) over a 4-minute mean treatment time.

Conclusions: Daily endorectal balloon consistently stabilizes the prostate, preventing clinically significant displacement (>5 mm). A 3-mm internal margin may sufficiently account for 95% of intrafraction prostate movement for up to 6 minutes of treatment time. Directional analysis suggests that the lateral internal margin could be further reduced to 2 mm.

Citing Articles

ACR-ARS Practice Parameter for the Performance of Proton Beam Therapy.

Frank S, Das I, Simone 2nd C, Davis B, Deville C, Liao Z Int J Part Ther. 2024; 13:100021.

PMID: 39347377 PMC: 11437389. DOI: 10.1016/j.ijpt.2024.100021.


Planning CT Identifies Patients at Risk of High Prostate Intrafraction Motion.

Ballhausen H, Li M, Lombardo E, Landry G, Belka C Cancers (Basel). 2023; 15(16).

PMID: 37627131 PMC: 10452220. DOI: 10.3390/cancers15164103.


Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer.

Feng S, Brouwer C, Korevaar E, Vapiwala N, Wang K, Deville Jr C Phys Imaging Radiat Oncol. 2023; 27:100474.

PMID: 37560512 PMC: 10407426. DOI: 10.1016/j.phro.2023.100474.


Reducing the margin in prostate radiotherapy: optimizing radiotherapy with a general-purpose linear accelerator using an in-house position monitoring system.

Arumugam S, Wong K, Do V, Sidhom M Front Oncol. 2023; 13:1116999.

PMID: 37519807 PMC: 10373585. DOI: 10.3389/fonc.2023.1116999.


Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 2: Feasibility of Margin Reduction for Fractionated Radiation Treatment with Advanced Image Guidance.

Laughlin B, Yu N, Lo S, Duan J, Welchel Z, Tinnon K Cancers (Basel). 2023; 15(1).

PMID: 36612040 PMC: 9817842. DOI: 10.3390/cancers15010040.